We have appointed prominent Australian entrepreneur, investor and digital-growth specialist Nick Bell as Strategic Adviser to support the commercial growth of our broader men’s health franchise.
As Strategic Adviser, Nick will work closely with LTR Pharma’s leadership team to identify and develop commercial opportunities across the Company’s expanding men’s health portfolio. His initial focus will include facilitating strategic introductions to telehealth platforms, clinic networks and commercial partners, advising on digital-health and patient-engagement strategies, and supporting the development of scalable and compliant commercial opportunities across the portfolio.
About Nick Bell
Nick has extensive experience building and scaling businesses across international markets. He founded WME, which was acquired by Melbourne IT in 2017, and has since built a portfolio of businesses spanning digital marketing, technology, healthcare and consumer services, including First Page. His commercial interests extend across digital health, telehealth, medical imaging and longevity, and he is widely recognised for his role as an investor on Shark Tank Australia.
LTR Pharma Executive Chairman, Lee Rodne: “Nick brings an exceptional track record of building and scaling businesses, particularly through digital channels. His entrepreneurial experience, commercial relationships and understanding of emerging healthcare markets make him a valuable addition to LTR Pharma.
As we expand our men’s-health portfolio, Nick will help us identify strategic partnerships, strengthen our digital-health strategy and evaluate compliant opportunities to connect eligible patients with appropriately qualified healthcare providers and treatment pathways.”
Nick Bell: “Men’s health is an area where digital innovation has the potential to significantly improve how patients connect with healthcare providers and access appropriate treatment. I’m excited to work with Lee and the LTR Pharma team to develop strategic partnerships, expand digital-health opportunities and help build scalable commercial pathways for the Company’s growing men’s-health portfolio.”